Anti-proline-glycine-proline or antielastin autoantibodies are not evident in chronic inflammatory lung disease

American Journal of Respiratory and Critical Care Medicine

Volumn 181, Issue 1, 2010, Pages 31-35

  Greene, Catherine M ^a   Low, Teck Boon ^a   O'Neill, Shane J ^a   McElvaney, Noel G ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

1 antitrypsin deficiency; Autoimmunity; Chronic obstructive pulmonary disease; Cystic fibrosis; IL 32

Indexed keywords

ALPHA 1 ANTITRYPSIN; ANTINUCLEAR ANTIBODY; AUTOANTIBODY; C REACTIVE PROTEIN; COLLAGEN; CORTICOSTEROID; CYTOKINE; ELASTIN; INTERLEUKIN 32; PROLYLGLYCYLPROLINE; TRIPEPTIDE; UNCLASSIFIED DRUG;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ANTIBODY DETECTION; ARTICLE; AUTOIMMUNITY; CHRONIC LUNG DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CYSTIC FIBROSIS; EMPHYSEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFLAMMATORY DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PLASMA; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ALPHA 1-ANTITRYPSIN DEFICIENCY; AUTOANTIBODIES; AUTOIMMUNE DISEASES; CASE-CONTROL STUDIES; CYSTIC FIBROSIS; ELASTIN; FEMALE; HUMANS; MALE; MIDDLE AGED; OLIGOPEPTIDES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; YOUNG ADULT;

EID: 73849127430     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.200904-0545OC     Document Type: Article

References (33)

1. Betsuyaku T, Nishimura M, Yoshioka A, Takeyabu K, Miyamoto K, Kawakami Y. Elastin-derived peptides and neutrophil elastase in bronchoalveolar lavage fluid. Am J Respir Crit Care Med 1996;154:720-724.
2. Weathington NM, van Houwelingen AH, Noerager BD, Jackson PL, Kraneveld AD, Galin FS, Folkerts G, Nijkamp FP, Blalock JE. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Nat Med 2006;12:317-323.
3. Reilly CF, Travis J. The degradation of human lung elastin by neutrophil proteinases. Biochim Biophys Acta 1980;621:147-157.
4. Gaggar A, Jackson PL, Noerager BD, O'Reilly PJ, McQuaid DB, Rowe SM, Clancy JP, Blalock JE. A novel proteolytic cascade generates an extracellular matrix-derived chemoattractant in chronic neutrophilic inflammation. J Immunol 2008;180:5662-5669.
5. Lin M, Jackson P, Tester AM, Diaconu E, Overall CM, Blalock JE, Pearlman E. Matrix metalloproteinase-8 facilitates neutrophil migration through the corneal stromal matrix by collagen degradation and production of the chemotactic peptide Pro-Gly-Pro. Am J Pathol 2008;173:144-153.
6. Bruce MC, Poncz L, Klinger JD, Stern RC, Tomashefski JF Jr, Dearborn DG. Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis. Am Rev Respir Dis 1985;132:529-535.
7. Gottlieb DJ, Luisetti M, Stone PJ, Allegra L, Cantey-Kiser JM, Grassi C, Snider GL. Short-term supplementation therapy does not affect elastin degradation in severe alpha(1)-antitrypsin deficiency. The American-Italian AATD Study Group. Am J Respir Crit Care Med 2000;162:2069-2072.
8. Morrison HM, Kramps JA, Burnett D, Stockley RA. Lung lavage fluid from patients with alpha 1-proteinase inhibitor deficiency or chronic obstructive bronchitis: anti-elastase function and cell profile. Clin Sci (Lond) 1987;72:373-381.
9. Houghton AM, Quintero PA, Perkins DL, Kobayashi DK, Kelley DG, Marconcini LA, Mecham RP, Senior RM, Shapiro SD. Elastin fragments drive disease progression in a murine model of emphysema. J Clin Invest 2006;116:753-759.
10. Lee SH, Goswami S, Grudo A, Song LZ, Bandi V, Goodnight-White S, Green L, Hacken-Bitar J, Huh J, Bakaeen F, Coxson HO, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007;13:567-569.
11. Cottin V, Fabien N, Khouatra C, Moreira A, Cordier J-F. Anti-elastin autoantibodies are not present in combined pulmonary fibrosis and emphysema. Eur Respir J 2009;33:219-220.
12. Calabrese F, Baraldo S, Bazzan E, Lunardi F, Rea F, Maestrelli P, Turato G, Lokar-Oliani K, Papi A, Zuin R, et al. IL-32, a novel proinflammatory cytokine in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;178:894-901.
13. Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA. Interleukin-32: a cytokine and inducer of TNFalpha. Immunity 2005;22:131-142.
14. Joosten LA, Netea MG, Kim SH, Yoon DY, Oppers-Walgreen B, Radstake TR, Barrera P, van de Loo FA, Dinarello CA, van den Berg WB. IL-32, a proinflammatory cytokine in rheumatoid arthritis. Proc Natl Acad Sci USA 2006;103:3298-3303.
15. Shioya M, Nishida A, Yagi Y, Ogawa A, Tsujikawa T, Kim-Mitsuyama S, Takayanagi A, Shimizu N, Fujiyama Y, Andoh A. Epithelial overexpression of interleukin-32alpha in inflammatory bowel disease. Clin Exp Immunol 2007;149:480-486.
16. Low TB, Greene CM, O'Neill SJ, McElvaney NG. Autoantibodies in cystic fibrosis. American Thoracic Society; 2009; San Diego [abstract]. Am J Respir Crit Care Med 2009;179:A2875.
17. Tan EM, Feltkamp TE, Smolen JS, Butcher B, Dawkins R, Fritzler MJ, Gordon T, Hardin JA, Kalden JR, Lahita RG, et al. Range of antinuclear antibodies in "healthy" individuals. Arthritis Rheum 1997;40:1601-1611.
18. Feghali-Bostwick CA, Gadgil AS, Otterbein LE, Pilewski JM, Stoner MW, Csizmadia E, Zhang Y, Sciurba FC, Duncan SR. Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008;177:156-163.
19. van Houwelingen AH, Weathington NM, Verweij V, Blalock JE, Nijkamp FP, Folkerts G. Induction of lung emphysema is prevented by L-arginine-threonine- arginine. FASEB J 2008;22:3403-3408.
20. Sorrentino C, Di Carlo E. Expression of IL-32 in human lung cancer is related to the histotype and metastatic phenotype. Am J Respir Crit Care Med 2009;180:769-779.
21. Nishida A, Andoh A, Inatomi O, Fujiyama Y. Interleukin-32 expression in the pancreas. J Biol Chem 2009;284:17868-17876.
22. Carlsson M, Eriksson L, Erwander I, Wieslander J, Segelmark M. Pseudomonas-induced lung damage in cystic fibrosis correlates to bactericidal-permeability increasing protein (BPI)-autoantibodies. Clin Exp Rheumatol 2003;21(6, Suppl 32)S95-S100.
23. Carlsson M, Eriksson L, Pressler T, Kornfält R, Mared L, Meyer P, Wiik A, Wieslander J, Segelmark M. Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis. J Cyst Fibros 2007;6:228-233.
24. Stechova K, Kolouskova S, Sumnik Z, Cinek O, Kverka M, Faresjo MK, Chudoba D, Dovolilova E, Pechova M, Vrabelova Z, et al. Anti-GAD65 reactive peripheral blood mononuclear cells in the pathogenesis of cystic fibrosis related diabetes mellitus. Autoimmunity 2005;38:319-323.
25. Minicucci L, Cotellessa M, Pittaluga L, Minuto N, d'Annunzio G, Avanzini MA, Lorini R. Beta-cell autoantibodies and diabetes mellitus family history in cystic fibrosis. J Pediatr Endocrinol Metab 2005;18:755-760.
26. Jensen P, Johansen HK, Carmi P, Hoiby N, Cohen IR. Autoantibodies to pancreatic hsp60 precede the development of glucose intolerance in patients with cystic fibrosis. J Autoimmun 2001;17:165-172.
27. Mahadeva R, Zhao MH, Stewart S, Cary N, Flower C, Lockwood M, Shneerson J. Vasculitis and bronchiectasis in a patient with antibodies to bactericidal/permeability-increasing protein and alpha1-antitrypsin deficiency. Chest 1997;112:1699-1701.
28. Esnault VL, Testa A, Audrain M, Roge C, Hamidou M, Barrier JH, Sesboü é R, Martin JP, Lesavre P. Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis. Kidney Int 1993;43:1329-1332.
29. Audrain MA, Sesboü é R, Baranger TA, Elliott J, Testa A, Martin JP, Lockwood CM, Esnault VL. Analysis of anti-neutrophil cytoplasmic antibodies (ANCA): frequency and specificity in a sample of 191 homozygous (PiZZ) alpha1-antitrypsin-deficient subjects. Nephrol Dial Transplant 2001;16:39-44.
30. Baydanoff S, Nicoloff G, Alexiev C. Age-dependent changes in the level of antielastin antibodies of different immunoglobulin classes (IgG, IgM, IgA and IgD) in the human serum. Cor Vasa 1991;33:197-205.
31. Colburn KK, Langga-Shariffi E, Kelly GT, Malto MC, Sandberg LB, Baydanoff S, Green LM. Abnormalities of serum antielastin antibodies in connective tissue diseases. J Investig Med 2003;51:104-109.
32. Nicoloff G, Blazhev A, Petrova C, Christova P, Jordanova-Laleva P, Dekov D, Dorovski P. Detection of free antielastin antibodies among diabetic children. J Investig Med 2005;53:128-134.
33. Nicoloff G, Weiss AS, Iotova V, Tzaneva V, Petrova C, Domuschieva N, Nikolov A, Tzvetanov P, Christova P. Abnormal levels of serum antielastin antibodies in children with diabetes mellitus type 1. J Investig Med 2006;54:461-467.